The classical D1 dopamine receptor antagonist SCH23390 is a functional sigma-1 receptor allosteric modulator.

GSK3β SCH23390 Sigma-1 receptor allosteric modulation pharmacological actions

Journal

Acta pharmacologica Sinica
ISSN: 1745-7254
Titre abrégé: Acta Pharmacol Sin
Pays: United States
ID NLM: 100956087

Informations de publication

Date de publication:
11 Apr 2024
Historique:
received: 19 10 2023
accepted: 28 02 2024
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 11 4 2024
Statut: aheadofprint

Résumé

SCH23390 is a widely used D

Identifiants

DOI: 10.1038/s41401-024-01256-1 PMID: 38605179
pubmed: 38605179
doi: 10.1038/s41401-024-01256-1
pii: 10.1038/s41401-024-01256-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Références

Bourne JA. SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev. 2001;7:399–414.
pubmed: 11830757 pmcid: 6741643 doi: 10.1111/j.1527-3458.2001.tb00207.x
Waddington JL, O’Boyle KM. Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D1 antagonist. Pharmacol Ther. 1989;43:1–52.
pubmed: 2675127 doi: 10.1016/0163-7258(89)90046-6
Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl). 1994;116:143–51.
pubmed: 7862943 doi: 10.1007/BF02245056
Kempadoo KA, Mosharov EV, Choi SJ, Sulzer D, Kandel ER. Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory. Proc Natl Acad Sci USA. 2016;113:14835–40.
pubmed: 27930324 pmcid: 5187750 doi: 10.1073/pnas.1616515114
Puig MV, Antzoulatos EG, Miller EK. Prefrontal dopamine in associative learning and memory. Neuroscience. 2014;282:217–29.
pubmed: 25241063 doi: 10.1016/j.neuroscience.2014.09.026
Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Akar FY, Celikyurt IK, et al. Effects of ziprasidone, SCH23390 and SB277011 on spatial memory in the Morris water maze test in naive and MK-801 treated mice. Pharmacol Biochem Behav. 2015;138:142–7.
pubmed: 26394282 doi: 10.1016/j.pbb.2015.09.014
Tao YM, Yu C, Wang WS, Hou YY, Xu XJ, Chi ZQ, et al. Heteromers of mu opioid and dopamine D
pubmed: 28608532 pmcid: 5554314 doi: 10.1111/bph.13908
Nesbit MO, Chai A, Axerio-Cilies P, Phillips AG, Wang YT, Held K. The selective dopamine D
pubmed: 35077763 doi: 10.1016/j.neuropharm.2022.108967
Yu Y, Wang JR, Sun PH, Guo Y, Zhang ZJ, Jin GZ, et al. Neuroprotective effects of atypical D
pubmed: 18005341 doi: 10.1111/j.1471-4159.2007.05062.x
Guo L, Zhao J, Jin G, Zhao B, Wang G, Zhang A, et al. SKF83959 is a potent allosteric modulator of sigma-1 receptor. Mol Pharmacol. 2013;83:577–86.
pubmed: 23295385 doi: 10.1124/mol.112.083840
Fukunaga K, Moriguchi S. Stimulation of the sigma-1 receptor and the effects on neurogenesis and depressive behaviors in mice. Adv Exp Med Biol. 2017;964:201–11.
pubmed: 28315273 doi: 10.1007/978-3-319-50174-1_14
Hashimoto K. Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication. J Pharmacol Sci. 2015;127:6–9.
pubmed: 25704012 doi: 10.1016/j.jphs.2014.11.010
Wang Y, Guo L, Jiang HF, Zheng LT, Zhang A, Zhen XC. Allosteric modulation of sigma-1 receptors elicits rapid antidepressant activity. CNS Neurosci Ther. 2016;22:368–77.
pubmed: 26854125 pmcid: 6492821 doi: 10.1111/cns.12502
Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18:e3000410.
pubmed: 32663219 pmcid: 7360023 doi: 10.1371/journal.pbio.3000410
Zhang G, Chen S, Jia J, Liu C, Wang W, Zhang H, et al. Development and evaluation of novel metformin derivative metformin threonate for brain ischemia treatment. Front Pharmacol. 2022;13:879690.
pubmed: 35800435 pmcid: 9253272 doi: 10.3389/fphar.2022.879690
Zhang G, Li Q, Tao W, Qin P, Chen J, Yang H, et al. Sigma-1 receptor-regulated efferocytosis by infiltrating circulating macrophages/microglial cells protects against neuronal impairments and promotes functional recovery in cerebral ischemic stroke. Theranostics. 2023;13:543–59.
pubmed: 36632219 pmcid: 9830433 doi: 10.7150/thno.77088
Wang M, Wan C, He T, Han C, Zhu K, Waddington JL, et al. Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection. Neuropharmacology. 2021;196:108360.
pubmed: 33122030 doi: 10.1016/j.neuropharm.2020.108360
Lasbleiz C, Peyrel A, Tarot P, Sarniguet J, Crouzier L, Cubedo N, et al. Sigma-1 receptor agonist PRE-084 confers protection against TAR DNA-binding protein-43 toxicity through NRF2 signalling. Redox Biol. 2022;58:102542.
pubmed: 36442393 pmcid: 9706169 doi: 10.1016/j.redox.2022.102542
Yano H, Bonifazi A, Xu M, Guthrie DA, Schneck SN, Abramyan AM, et al. Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays. Neuropharmacology. 2018;133:264–75.
pubmed: 29407216 pmcid: 5858991 doi: 10.1016/j.neuropharm.2018.01.042
Huang W, Zuo W, Chen L, Wang L, Tewfik G, Fu R, et al. Acetaldehyde excitation of lateral habenular neurons via multiple cellular mechanisms. J Neurosci. 2021;41:7532–45.
pubmed: 34326141 pmcid: 8425984 doi: 10.1523/JNEUROSCI.2913-20.2021
Calvo B, Fernandez M, Rincon M, Tranque P. GSK3beta inhibition by phosphorylation at Ser(389) controls neuroinflammation. Int J Mol Sci. 2022;24:337.
pubmed: 36613781 pmcid: 9820301 doi: 10.3390/ijms24010337
Yan N, Xie F, Tang LQ, Wang DF, Li X, Liu C, et al. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3beta inhibitors for Alzheimer’s disease. Bioorg Chem. 2023;138:106663.
pubmed: 37329814 doi: 10.1016/j.bioorg.2023.106663
Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, et al. The concise guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol. 2013;170:1449–58.
pubmed: 24528237 pmcid: 3892286 doi: 10.1111/bph.12444
Alon A, Schmidt HR, Wood MD, Sahn JJ, Martin SF, Kruse AC. Identification of the gene that codes for the sigma(2) receptor. Proc Natl Acad Sci USA. 2017;114:7160–5.
pubmed: 28559337 pmcid: 5502638 doi: 10.1073/pnas.1705154114
Haller JL, Panyutin I, Chaudhry A, Zeng C, Mach RH, Frank JA. Sigma-2 receptor as potential indicator of stem cell differentiation. Mol Imaging Biol. 2012;14:325–35.
pubmed: 21614680 pmcid: 3164741 doi: 10.1007/s11307-011-0493-3
Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol. 1994;268:9–18.
pubmed: 7925616 doi: 10.1016/0922-4106(94)90115-5
Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992;13:85–6.
pubmed: 1315463 doi: 10.1016/0165-6147(92)90030-A
Chen AF, Ma WH, Xie XY, Huang YS. Sigma-2 receptor as a potential drug target. Curr Med Chem. 2021;28:4172–89.
pubmed: 32881653 doi: 10.2174/0929867327666200902172615
Riad A, Lengyel-Zhand Z, Zeng C, Weng CC, Lee VM, Trojanowski JQ, et al. The sigma-2 receptor/TMEM97, PGRMC1, and LDL receptor complex are responsible for the cellular uptake of Abeta42 and its protein aggregates. Mol Neurobiol. 2020;57:3803–13.
pubmed: 32572762 pmcid: 7415709 doi: 10.1007/s12035-020-01988-1
Vavers E, Zvejniece L, Dambrova M. Sigma-1 receptor and seizures. Pharmacol Res. 2023;191:106771.
pubmed: 37068533 pmcid: 10176040 doi: 10.1016/j.phrs.2023.106771
Ye N, Qin W, Tian S, Xu Q, Wold EA, Zhou J, et al. Small molecules selectively targeting sigma-1 receptor for the treatment of neurological diseases. J Med Chem. 2020;63:15187–217.
pubmed: 33111525 doi: 10.1021/acs.jmedchem.0c01192
Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca
pubmed: 17981125 doi: 10.1016/j.cell.2007.08.036
Maurice T. Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders. Expert Opin Drug Discov. 2021;16:373–89.
pubmed: 33070647 doi: 10.1080/17460441.2021.1838483
Crouzier L, Couly S, Roques C, Peter C, Belkhiter R, Arguel Jacquemin M, et al. Sigma-1 (sigma(1)) receptor activity is necessary for physiological brain plasticity in mice. Eur Neuropsychopharmacol. 2020;39:29–45.
pubmed: 32893057 doi: 10.1016/j.euroneuro.2020.08.010
Jia J, Cheng J, Wang C, Zhen X. Sigma-1 receptor-modulated neuroinflammation in neurological diseases. Front Cell Neurosci. 2018;12:314.
pubmed: 30294261 pmcid: 6158303 doi: 10.3389/fncel.2018.00314
Ryskamp DA, Korban S, Zhemkov V, Kraskovskaya N, Bezprozvanny I. Neuronal sigma-1 receptors: signaling functions and protective roles in neurodegenerative diseases. Front Neurosci. 2019;13:862.
pubmed: 31551669 pmcid: 6736580 doi: 10.3389/fnins.2019.00862
Su TP, Su TC, Nakamura Y, Tsai SY. The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci. 2016;37:262–78.
pubmed: 26869505 pmcid: 4811735 doi: 10.1016/j.tips.2016.01.003
Vavers E, Zvejniece L, Maurice T, Dambrova M. Allosteric modulators of sigma-1 receptor: a review. Front Pharmacol. 2019;10:223.
pubmed: 30941035 pmcid: 6433746 doi: 10.3389/fphar.2019.00223
Guo L, Chen Y, Zhao R, Wang G, Friedman E, Zhang A, et al. Allosteric modulation of sigma-1 receptors elicits anti-seizure activities. Br J Pharmacol. 2015;172:4052–65.
pubmed: 25989224 pmcid: 4543612 doi: 10.1111/bph.13195
Zvejniece L, Vavers E, Svalbe B, Vilskersts R, Domracheva I, Vorona M, et al. The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors. Br J Pharmacol. 2014;171:761–71.
pubmed: 24490863 pmcid: 3969087 doi: 10.1111/bph.12506
Wu Z, Li L, Zheng LT, Xu Z, Guo L, Zhen X. Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation. J Neurochem. 2015;134:904–14.
pubmed: 26031312 doi: 10.1111/jnc.13182
Scerbina T, Chatterjee D, Gerlai R. Dopamine receptor antagonism disrupts social preference in zebrafish: a strain comparison study. Amino Acids. 2012;43:2059–72.
pubmed: 22491827 pmcid: 3425734 doi: 10.1007/s00726-012-1284-0

Auteurs

Gu-Fang Zhang (GF)

Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Kai-Lian Zhu (KL)

Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Qi Li (Q)

Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.

Yue Zhang (Y)

Suzhou Medical College, Soochow University, Suzhou, 215123, China.

John L Waddington (JL)

Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China.
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

Xiang-Dong Du (XD)

Department of Psychiatry, The Affiliated Guangji Hospital of Soochow University, Suzhou, 215003, China. xiangdong-du@163.com.

Xue-Chu Zhen (XC)

Jiangsu Key Laboratory of Neuropsychiatric Diseases and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, China. zhenxuechu@suda.edu.cn.

Classifications MeSH